Smithkline Beecham Corporation

Glazo Group Limited

Paul William Oxley

Robert Gordon Giles

Norman John Lewis

Michael Anthony Forth

John Kirby Quick

Clemens Michael Helmut Brechtelsbauer

Toby Broom

Monica Delpogetto

Richard Atkins

Alan Negus

Alan Collier

Darren Hewitt

Disclosed is a novel polymorphic form of the compound of formula (I) also known as mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-ylsulfanyl)-acetate, a process for the preparation of the polymorphic form, pharmaceutical compositions comprising the polymorphic form, and the use of the polymorphic form in medicine, particularly in antibacterial therapy.

Polymorph of mutilin

Disclosed is the compound (+)-(2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol and pharmaceutically acceptable salts and solvates thereof, methods for preparing them, pharmaceutical compositions comprising them, and processes for their preparation; also disclosed is a method of treating depression, attention deficit hyperactivity disorder (ADHD), obesity, migraine, sexual dysfunction, Parkinson's disease, Alzheimer's disease, or addiction to cocaine or nicotine-containing (especially tobacco) products using such compound, salts, solvates or compositions.

Pharmaceutically active morpholinol

This invention relates to a method for preparing 1-oxaspiro&lsqb;2,5&rsqb;-carbonitriles from ketones using spinning disc reactor technology.

Process for epoxidizing substituted cyclohexanones

Process for the production of tetrazolylbenzopyrans

Process for the preparation of benzopyran compounds

Growing community of inventors

Kent, United Kingdom

Paul William Oxley